A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin’s lymphoma-Reference-Cited by-同舟云学术

A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin’s lymphoma

Published:2023-01-16 Issue:2 Volume:102 Page:385-392
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Gaudio Francesco^ORCID,Loseto Giacomo,Bozzoli Valentina,Scalzulli Potito Rosario,Mazzone Anna Maria,Tonialini Lorenzo,Fesce Vincenza,Quintana Giovanni,De Santis Gaetano,Masciopinto Pierluigi,Arcuti Elena,Clemente Felice,Scardino Stefania,Tarantini Giuseppe,Pastore Domenico,Melillo Lorella,Pavone Vincenzo,Maggi Alessandro,Carella Angelo Michele,Di Renzo Nicola,Guarini Attilio,Musto Pellegrino

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-023-05100-0.pdf

Reference31 articles.

1. Gaudio F, Giordano A, Pavone V, Perrone T, Curci P, Pastore D, Delia M, De' Risi C, Spina A, Liso V, Specchia G (2011) Outcome of very late relapse in patients with Hodgkin's Lymphomas. Adv Hematol 2011:707542. https://doi.org/10.1155/2011/707542

2. Laddaga FE, Moschetta M, Perrone T, Perrini S, Colonna P, Ingravallo G, D’abbicco D, Specchia G, Gaudio F (2020) Long-term Hodgkin Lymphoma survivors: a glimpse of what happens 10 years after treatment. Clin Lymphoma Myeloma Leuk 20(8):e506–e512. https://doi.org/10.1016/j.clml.2020.03.006

3. Domingo-Domènech E, Sureda A (2020) Treatment of Hodgkin Lymphoma Relapsed after Autologous Stem Cell Transplantation. J Clin Med 9(5):1384. https://doi.org/10.3390/jcm9051384

4. Voorhees TJ, Beaven AW (2020) Therapeutic updates for relapsed and refractory classical hodgkin lymphoma. Cancers (Basel) 12(10):1–16. https://doi.org/10.3390/cancers12102887

5. di Renzo N, Gaudio F, Stella CC et al (2020) Relapsing/refractory hl after autotransplantation: which treatment? Acta Biomedica 91(S-5). https://doi.org/10.23750/abm.v91iS-5.9912

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin’s lymphoma;Journal of Clinical and Experimental Hematopathology;2024

2. Sequencing novel agents in the treatment of classical Hodgkin lymphoma;Expert Review of Hematology;2023-11-16